ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.260
-0.140 (-5.83%)
At close: Nov 3, 2025, 4:00 PM EST
2.270
+0.010 (0.44%)
Pre-market: Nov 4, 2025, 5:56 AM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $2.23 billion as of November 4, 2025. Its market cap has decreased by -13.86% in one year.
Market Cap
2.23B
Enterprise Value
2.92B
1-Year Change
-13.86%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since July 28, 2015, ImmunityBio's market cap has decreased from $2.67B to $2.23B, a decrease of -16.50%. That is a compound annual growth rate of -1.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 2.27B | 27.17% |
| Dec 31, 2024 | 1.78B | -46.78% |
| Dec 29, 2023 | 3.35B | 65.16% |
| Dec 30, 2022 | 2.03B | -16.05% |
| Dec 31, 2021 | 2.42B | 67.01% |
| Dec 31, 2020 | 1.45B | 288.28% |
| Dec 31, 2019 | 372.80M | 305.66% |
| Dec 31, 2018 | 91.90M | -74.24% |
| Dec 29, 2017 | 356.80M | -24.28% |
| Dec 30, 2016 | 471.20M | -66.52% |
| Dec 31, 2015 | 1.41B | -47.21% |
| Jul 28, 2015 | 2.67B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |